| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 7.802 | 7.969 | 5.269 | 65.215 | 57.937 | 60.307 |
| Total Income - EUR | - | - | - | - | 7.802 | 7.971 | 5.272 | 65.221 | 57.943 | 60.626 |
| Total Expenses - EUR | - | - | - | - | 2.651 | 22.539 | 14.551 | 38.319 | 69.254 | 67.775 |
| Gross Profit/Loss - EUR | - | - | - | - | 5.151 | -14.568 | -9.279 | 26.903 | -11.312 | -7.149 |
| Net Profit/Loss - EUR | - | - | - | - | 5.073 | -14.642 | -9.389 | 26.264 | -11.891 | -8.958 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 3 |
Check the financial reports for the company - Octasan-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 64 | 18.345 | 15.682 | 9.439 | 11.088 | 7.471 |
| Current Assets | - | - | - | - | 7.656 | 3.519 | 7.339 | 26.420 | 20.526 | 26.719 |
| Inventories | - | - | - | - | 1.283 | 2.643 | 2.803 | 3.621 | 3.610 | 0 |
| Receivables | - | - | - | - | 0 | 200 | 196 | 3.720 | 12.483 | 687 |
| Cash | - | - | - | - | 6.374 | 676 | 4.340 | 19.079 | 4.433 | 26.032 |
| Shareholders Funds | - | - | - | - | 5.115 | -9.624 | -18.799 | 7.406 | -4.507 | -13.440 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 2.606 | 31.488 | 41.820 | 28.452 | 36.122 | 47.630 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Octasan-Med S.r.l.